Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors

Lupus

Volumn 18, Issue 9, 2009, Pages 845-847

  Aoun, E G ^a   Musallam, K M ^a   Uthman, I ^a   Beydoun, A ^a   El Hajj, T ^a   Taher, A T ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Childhood; Familial mediterranean fever; Stroke; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; C REACTIVE PROTEIN; COLCHICINE; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; STEROID;

ADOLESCENT; ANAMNESIS; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC ERROR; DIPLOPIA; DYSARTHRIA; DYSPHONIA; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GAIT; GENE MUTATION; GUILLAIN BARRE SYNDROME; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LABORATORY TEST; MICROALBUMINURIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSORY DYSFUNCTION; STROKE; TEMPERATURE SENSE; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; CONSANGUINITY; FACTOR V; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; RISK FACTORS; STROKE;

EID: 67650616267     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309103057     Document Type: Article

References (10)

1. El-Shanti H, Majeed HA, El-Khateeb M. Familial mediterranean fever in Arabs. Lancet 2006; 367: 1016-1024.
2. Aksu G, Ozturk C, Kavakli K, et al. Hypercoagulability: Interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol 2007; 26: 366-370.
3. Lynch JK, Nelson KB. Epidemiology of perinatal stroke. Curr Opin Pediatr 2001; 13: 499-505.
4. Schoenberg BS, Mellingier JF, Schoenberg DG. Cerebrovascular disease in infants and children: A study of incidence, clinical features and survival. Neurology 1978; 28: 763-768.
5. Andrew M, David M, deVeber G, et al. Arterial thromboembolic complications in paediatric patients. Thromb Haemost 1997; 78: 715-725.
6. Taher A, Khalil I, Shamseddine A, et al. High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: Is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 2001; 86: 723-724.
7. Duran R, Biner B, Demir M, et al. Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost 2005; 11: 83-88.
8. Nowak-Göttl U, Sträter R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetra-hydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999; 94: 3678-3682.
9. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000; 31: 1283-1288.
10. Grabowski EF, Buonanno FS, Krishnamoorthy K. Prothrombotic Risk Factors in the Evaluation andManagement of Perinatal Stroke. Semin Perinatol 2007; 31: 243-249.